The Distribution of Activation Markers and Selectins on Peripheral T Lymphocytes in Preeclampsia

Table 2

Prevalence of the investigated cell subsets.

	Healthy pregnancy ()	Preeclampsia ()	value
Activation markers
CD4+ CD69+/CD4+	2.28 (1.77–3.27)	2.61 (1.68–2.97)	0.8151
CD4+ CD25+/CD4+	7.38 (5.39–9.64)	9.51 (5.03–12.70)	0.5686
CD4+ HLA-DR+/CD4+	6.19 (3.02–13.73)	21.05 (9.98–46.03)	0.0075
CD4+ CD122+/CD4+	1.20 (0.67–1.81)	1.63 (1.20–2.28)	0.0437
CD11c+/monocytes	2.57 (1.94–3.83)	2.43 (1.39–4.39)	0.5827
Selectins
CD4+ CD62E+/CD4+	5.77 (2.26–10.96)	16.10 (8.25–38.80)	0.0141
CD4+ CD62L+/CD4+	1.74 (1.03–3.64)	2.91 (2.49–4.30)	0.0124
CD4+ CD62P+/CD4+	9.53 (5.04–19.05)	10.70 (8.54–13.20)	0.6068

Data are presented as median (interquartile range). versus healthy pregnant women.